Evidence map›Paper›PMID 33646152›Full record

ArticleJournal of Alzheimer's disease : JAD2021

Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

Ryan J Piers, Yulin Liu, Ting F A Ang, Qiushan Tao, Rhoda Au, Wei Qiao Qiu

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Association of theJournal of personalized medicine · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. APOE4 Status and Cognitive Function in Middle-aged and Elderly People.Balkan journal of medical genetics : BJMG · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ryan J PiersDepartment of Psychological and Brain Sciences, Boston University, Boston, MA, USA.
Yulin LiuThe Framingham Heart Study, Boston University School of Medicine, Boston, MA, USA.
Ting F A AngThe Framingham Heart Study, Boston University School of Medicine, Boston, MA, USA.
Qiushan TaoDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Rhoda AuThe Framingham Heart Study, Boston University School of Medicine, Boston, MA, USA.
Wei Qiao QiuDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Boston University · USFramingham Heart Study · US

Funding

TBDU19AG068753 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Lindsay A. Farrer · 2020 to 2026
$42.4M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
RL5: Research Education CoreP30AG072978 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Ann C. McKee · 2021 to 2026
$25.6M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
EPIDEMIOLOGY OF DEMENTIA IN THE FRAMINGHAM STUDYR01AG008122 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 1989 to 2015
$14.4M
MRI, Genetics &Cognitive Precursors of AD &DementiaR01AG016495 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 1999 to 2016
$12.5M
MRI, Cognitive, Genetic & Biomarker Precursors of AD & Dementia in Young AdultsR01AG033040 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 2009 to 2019
$11.2M
Multi-center development of a novel diagnostic test for Alzheimer's diseaseR01AG059424 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARLOW, MARTIN RHYS, KOWALL, NEIL W. · 2018 to 2022
$6.4M
Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial FindingsR01AG049810 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BONDI, MARK W, EDLAND, STEVEN DYAL · 2016 to 2020
$3.7M
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive declineRF1AG054156 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, RYU, HOON · 2016 to 2018
$3.4M
Plasma Amylin Impact on Cognitive Function and Brain Morphology in the Framingham Heart StudyR01AG049899 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, QIU, WEI QIAO WENDY · 2015 to 2019
$2.3M
Cognitive Heterogeneity in those with high Alzheimer's Disease RiskRF1AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 2020 to 2021
$1.8M
NHLBI NIH HHS HHSN268201500001CNHLBI NIH HHS HHSN268201500001INHLBI NIH HHS N01 HC025195NIA NIH HHS K24 AG050842NIA NIH HHS P30 AG013846NIA NIH HHS P30 AG072978NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG016495NIA NIH HHS R01 AG033040NIA NIH HHS R01 AG049810NIA NIH HHS R01 AG049899NIA NIH HHS R01 AG059424NIA NIH HHS R01 AG062109NIA NIH HHS R56 AG062109NIA NIH HHS RF1 AG054156NIA NIH HHS RF1 AG062109NIA NIH HHS U19 AG068753NINDS NIH HHS R01 NS017950
6 · The paper itself

Abstract

backgroundDepression and Apolipoprotein E4 (APOE4) are associated with decreased cognitive function and differences in brain structure.

objectiveThis study investigated whether APOE4 status moderates the association between elevated depressive symptoms, cognitive function, and brain structure.

methodsStroke- and dementia-free participants (n = 1,968) underwent neuropsychological evaluation, brain MRI, and depression screening. Linear and logistic regression was used to examine all associations. Secondary analyses were performed using interaction terms to assess effect modification by APOE4 status.

resultsElevated depressive symptoms were associated with lower cognitive performance in several domains. In stratified analyses, elevated depressive symptoms were associated with poorer visual short- and long-term memory performance for APOE4 + participants. Elevated depressive symptoms were not associated with any brain structure in this study sample.

conclusionElevated depressive symptoms impact cognitive function in non-demented individuals. Having the APOE4 allele may exacerbate the deleterious effects of elevated depressive symptoms on visual memory performance. Screening for elevated depressive symptoms in both research studies and clinical practice may be warranted to avoid false positive identification of neurodegeneration, particularly among those who are APOE4 + .

Indexed as

AdultAgedAged, 80 and overApolipoprotein E4CognitionCognitive DysfunctionDepressionFemaleGenetic Predisposition to DiseaseHumansLongitudinal StudiesMaleMiddle AgedApolipoprotein E4APOE4cognitiondepressionframingham offspring studymagnetic resonance imaging

Identifiers

PMID33646152
PMCPMC8172078
OpenAlexW3134426926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.